Form 4: Aspira Women's Health Director Exercises Restricted Stock Units
SEC Form 4
Director Jannie Prestridge Herchuk converted 8,438 restricted stock units into common stock of Aspira Women's Health Inc. on March 31, 2025.
Summary
- Jannie Prestridge Herchuk, a director of Aspira Women's Health Inc., converted 8,438 restricted stock units (RSUs) into common stock on March 31, 2025.
- The RSUs vested on March 31, 2025, as part of a grant of 33,750 RSUs awarded on August 22, 2024.
- Following the transaction, Herchuk directly owns 74,065 shares of common stock and 8,437 RSUs.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting the standard vesting of previously granted equity compensation.
Industry Context
This is a routine disclosure of insider transactions, which are common and expected. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The transaction increases the number of outstanding shares, which could have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 08/22/2024 | Reporting person was granted 33,750 RSUs |
| 08/26/2024 | Previous Form 4 filing date related to the RSU grant. |
| 03/31/2025 | 8,438 RSUs vested and were converted into common stock. |
| 04/01/2025 | Date of signature on the Form 4. |
Keywords
Aspira Women's Health, Director, Insider Trading, Form 4, RSU, Stock Options, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.